Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
India
201617023312
Filed on 2014-12-16
201617023312
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Hong Kong
17105504.9
Filed on 2017-06-02
17105504.9
Filed on 2017-06-02
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
China
201480074163.2
Filed on 2014-12-16
201480074163.2
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Brazil
BR112016013804-0
Filed on 2014-12-16
BR112016013804-0
Filed on 2014-12-16
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE
Patent Cooperation Treaty
PCT/US2016/052496
Filed on 2016-09-19
PCT/US2016/052496
Filed on 2016-09-19
Reversible Regulation Of Intein Activity Through Engineered New Zinc Binding Domain
US Patent 9,796,967
Filed on 2015-01-30
Filed on 2015-01-30
Selective Propagation, Maintenance, And Induction Of Nephron Stem Cells
Japan
2015-139271
Filed on 2015-07-27
2015-139271
Filed on 2015-07-27
Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies
United Kingdom
06734177.6
Filed on 2006-02-01
06734177.6
Filed on 2006-02-01
Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies
France
06734177.6
Filed on 2006-02-01
06734177.6
Filed on 2006-02-01